Surgical Approaches for Implanting Xen Gel Stent without Conjunctival Dissection

The XEN Gel Stent (Allergan Inc., an Abbvie company) is an implant that lowers intraocular pressure by creating a filtration pathway from the anterior chamber to the subconjunctival space, using the same pathway as trabeculectomy. While the primary method for implantation is via ab interno approach,...

Descripción completa

Detalles Bibliográficos
Autores principales: Vera, Vanessa, Gagne, Sebastien, Myers, Jonathan S, Ahmed, Iqbal Ike K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445523/
https://www.ncbi.nlm.nih.gov/pubmed/32903875
http://dx.doi.org/10.2147/OPTH.S265695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445523/
https://www.ncbi.nlm.nih.gov/pubmed/32903875
http://dx.doi.org/10.2147/OPTH.S265695

Ejemplares similares